vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.
Vital Farms, Inc. is the larger business by last-quarter revenue ($213.6M vs $185.2M, roughly 1.2× AMICUS THERAPEUTICS, INC.). Vital Farms, Inc. runs the higher net margin — 7.6% vs 0.9%, a 6.7% gap on every dollar of revenue. On growth, Vital Farms, Inc. posted the faster year-over-year revenue change (28.7% vs 23.7%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-32.1M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 20.2%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".
FOLD vs VITL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $213.6M |
| Net Profit | $1.7M | $16.3M |
| Gross Margin | 85.7% | 35.8% |
| Operating Margin | 8.6% | 10.0% |
| Net Margin | 0.9% | 7.6% |
| Revenue YoY | 23.7% | 28.7% |
| Net Profit YoY | -88.5% | 54.3% |
| EPS (diluted) | $0.00 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $213.6M | ||
| Q3 25 | $169.1M | $198.9M | ||
| Q2 25 | $154.7M | $184.8M | ||
| Q1 25 | $125.2M | $162.2M | ||
| Q4 24 | $149.7M | $166.0M | ||
| Q3 24 | $141.5M | $145.0M | ||
| Q2 24 | $126.7M | $147.4M | ||
| Q1 24 | $110.4M | $147.9M |
| Q4 25 | $1.7M | $16.3M | ||
| Q3 25 | $17.3M | $16.4M | ||
| Q2 25 | $-24.4M | $16.6M | ||
| Q1 25 | $-21.7M | $16.9M | ||
| Q4 24 | $14.7M | $10.6M | ||
| Q3 24 | $-6.7M | $7.4M | ||
| Q2 24 | $-15.7M | $16.3M | ||
| Q1 24 | $-48.4M | $19.0M |
| Q4 25 | 85.7% | 35.8% | ||
| Q3 25 | 88.5% | 37.7% | ||
| Q2 25 | 90.2% | 38.9% | ||
| Q1 25 | 90.7% | 38.5% | ||
| Q4 24 | 90.1% | 36.1% | ||
| Q3 24 | 90.6% | 36.9% | ||
| Q2 24 | 91.1% | 39.1% | ||
| Q1 24 | 87.7% | 39.8% |
| Q4 25 | 8.6% | 10.0% | ||
| Q3 25 | 20.3% | 10.8% | ||
| Q2 25 | -6.1% | 12.9% | ||
| Q1 25 | -6.3% | 13.4% | ||
| Q4 24 | 10.7% | 7.8% | ||
| Q3 24 | 15.3% | 6.4% | ||
| Q2 24 | 11.8% | 11.6% | ||
| Q1 24 | -25.1% | 16.3% |
| Q4 25 | 0.9% | 7.6% | ||
| Q3 25 | 10.2% | 8.3% | ||
| Q2 25 | -15.8% | 9.0% | ||
| Q1 25 | -17.3% | 10.4% | ||
| Q4 24 | 9.8% | 6.4% | ||
| Q3 24 | -4.8% | 5.1% | ||
| Q2 24 | -12.4% | 11.1% | ||
| Q1 24 | -43.9% | 12.9% |
| Q4 25 | $0.00 | $0.35 | ||
| Q3 25 | $0.06 | $0.36 | ||
| Q2 25 | $-0.08 | $0.36 | ||
| Q1 25 | $-0.07 | $0.37 | ||
| Q4 24 | $0.05 | $0.23 | ||
| Q3 24 | $-0.02 | $0.16 | ||
| Q2 24 | $-0.05 | $0.36 | ||
| Q1 24 | $-0.16 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $48.8M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $351.3M |
| Total Assets | $949.9M | $518.7M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $48.8M | ||
| Q3 25 | $263.8M | $93.8M | ||
| Q2 25 | $231.0M | $108.2M | ||
| Q1 25 | $250.6M | $156.3M | ||
| Q4 24 | $249.9M | $150.6M | ||
| Q3 24 | $249.8M | $149.5M | ||
| Q2 24 | $260.1M | $133.2M | ||
| Q1 24 | $239.6M | $113.8M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $351.3M | ||
| Q3 25 | $230.4M | $331.2M | ||
| Q2 25 | $204.3M | $309.8M | ||
| Q1 25 | $193.6M | $288.9M | ||
| Q4 24 | $194.0M | $269.3M | ||
| Q3 24 | $178.8M | $253.4M | ||
| Q2 24 | $132.5M | $238.4M | ||
| Q1 24 | $130.7M | $213.3M |
| Q4 25 | $949.9M | $518.7M | ||
| Q3 25 | $868.8M | $481.5M | ||
| Q2 25 | $815.3M | $430.8M | ||
| Q1 25 | $789.8M | $376.9M | ||
| Q4 24 | $785.0M | $359.3M | ||
| Q3 24 | $786.6M | $344.7M | ||
| Q2 24 | $749.5M | $320.5M | ||
| Q1 24 | $721.8M | $300.2M |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $5.8M |
| Free Cash FlowOCF − Capex | $16.0M | $-32.1M |
| FCF MarginFCF / Revenue | 8.6% | -15.1% |
| Capex IntensityCapex / Revenue | 0.2% | 17.8% |
| Cash ConversionOCF / Net Profit | 9.62× | 0.35× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $-48.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $5.8M | ||
| Q3 25 | $35.7M | $23.4M | ||
| Q2 25 | $-26.5M | $-761.0K | ||
| Q1 25 | $7.8M | $5.3M | ||
| Q4 24 | $-3.9M | $14.8M | ||
| Q3 24 | $-23.0M | $10.0M | ||
| Q2 24 | $22.7M | $16.1M | ||
| Q1 24 | $-29.7M | $23.9M |
| Q4 25 | $16.0M | $-32.1M | ||
| Q3 25 | $35.3M | $-10.6M | ||
| Q2 25 | $-28.9M | $-7.6M | ||
| Q1 25 | $7.5M | $2.1M | ||
| Q4 24 | $-4.2M | $-3.4M | ||
| Q3 24 | $-23.3M | $6.4M | ||
| Q2 24 | $21.6M | $10.5M | ||
| Q1 24 | $-31.5M | $22.6M |
| Q4 25 | 8.6% | -15.1% | ||
| Q3 25 | 20.9% | -5.3% | ||
| Q2 25 | -18.7% | -4.1% | ||
| Q1 25 | 6.0% | 1.3% | ||
| Q4 24 | -2.8% | -2.0% | ||
| Q3 24 | -16.5% | 4.4% | ||
| Q2 24 | 17.0% | 7.2% | ||
| Q1 24 | -28.5% | 15.3% |
| Q4 25 | 0.2% | 17.8% | ||
| Q3 25 | 0.2% | 17.1% | ||
| Q2 25 | 1.6% | 3.7% | ||
| Q1 25 | 0.2% | 1.9% | ||
| Q4 24 | 0.2% | 10.9% | ||
| Q3 24 | 0.3% | 2.5% | ||
| Q2 24 | 0.9% | 3.8% | ||
| Q1 24 | 1.6% | 0.9% |
| Q4 25 | 9.62× | 0.35× | ||
| Q3 25 | 2.06× | 1.43× | ||
| Q2 25 | — | -0.05× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | -0.27× | 1.40× | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | 0.99× | ||
| Q1 24 | — | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
VITL
| Eggs And Egg Related Products | $205.8M | 96% |
| Butter And Butter Related Products | $7.7M | 4% |
